Delivery Order SPE2DR25D9239-SPE2DR26FFBW2
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $23,149.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cerdelga 84 mg capsules. The delivery order, issued on January 9, 2026, with an ultimate completion date of February 2, 2026, carries no set-aside designation, indicating the vendor competed in an unrestricted procurement. This award is issued under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $22,020.61 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cerdelga 84 mg capsules (14-count units). The delivery order, issued on October 27, 2025, with completion targeted for November 18, 2025, carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $32,185.93 for Cerdelga 84 mg capsules (14-count packages). This firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a specific product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The company was...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract, valued at $30,046.61, is for the delivery of Cerdelga 84 mg capsules. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $32,185.93 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 84mg capsules of the pharmaceutical product CERDELGA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $21,891.08 by the Defense Logistics Agency on September 22, 2025, for the supply of Cerdelga 84 mg capsules (quantity: 14 units). This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, carries no set-aside designation and represents work performed under DMS Pharmaceutical Group's larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,185.93 firm fixed-price delivery order is for the supply of 4565675719 CERDELGA 84 MG CAPSULE 14S, with an ultimate completion date of August 6, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to issue...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,185.93 firm fixed-price contract is for the delivery of 4566706859 Cerdelga 84 mg capsules. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Cerdelga 84 mg capsules. The $30,046.61 order calls for 14 units of the medication to be delivered to a facility in Park Ridge, Illinois by November 17, 2023. DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract with the Defense Logistics Agency to directly supply prescription medications and services to support...
- The Defense Logistics Agency issued a delivery order valued at $27,248.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Cerezyme 400 unit vials. This firm fixed-price delivery order was awarded on December 8, 2025, with an ultimate completion date of December 30, 2025, and was issued without set-aside designation, reflecting the vendor's competitive capability in unrestricted federal...
- SPE2DR25D9239Indefinite Delivery Contract
- SPE2DR25D9239-SPE2DR26FFBW2Delivery Order
The Defense Logistics Agency awarded a $23,149.91 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cerdelga 84 mg capsules (14-count units). The award, issued on January 13, 2026, with an ultimate completion date of February 4, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors for military healthcare facilities worldwide. DMS Pharmaceutical Group has served as a critical pharmaceutical supplier for Department of Defense operations since being awarded its PPV-G GEN V master contract on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036. The company's established performance across numerous delivery orders demonstrates its capability to fulfill diverse pharmaceutical requirements for the federal military medical system. As the prime contractor on this delivery order, DMS Pharmaceutical Group leverages its comprehensive product portfolio and established federal contracting experience to support recurring medical supply needs of DoD healthcare operations globally, with no identified subcontractors for this particular award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.1k | 1/12/26 |